AU6252296A - 1,6-disubstituted isochromans for treatment of migraine headaches - Google Patents
1,6-disubstituted isochromans for treatment of migraine headachesInfo
- Publication number
- AU6252296A AU6252296A AU62522/96A AU6252296A AU6252296A AU 6252296 A AU6252296 A AU 6252296A AU 62522/96 A AU62522/96 A AU 62522/96A AU 6252296 A AU6252296 A AU 6252296A AU 6252296 A AU6252296 A AU 6252296A
- Authority
- AU
- Australia
- Prior art keywords
- isochromans
- disubstituted
- treatment
- migraine headaches
- headaches
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/76—Benzo[c]pyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74195P | 1995-06-30 | 1995-06-30 | |
US000741 | 1995-06-30 | ||
US1123496P | 1996-02-06 | 1996-02-06 | |
US011234 | 1996-02-06 | ||
PCT/US1996/008681 WO1997002259A1 (en) | 1995-06-30 | 1996-06-07 | 1,6-disubstituted isochromans for treatment of migraine headaches |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6252296A true AU6252296A (en) | 1997-02-05 |
Family
ID=26668092
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU62522/96A Abandoned AU6252296A (en) | 1995-06-30 | 1996-06-07 | 1,6-disubstituted isochromans for treatment of migraine headaches |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0836599A1 (en) |
JP (1) | JPH11509532A (en) |
AU (1) | AU6252296A (en) |
BR (1) | BR9609631A (en) |
CA (1) | CA2225282A1 (en) |
CZ (1) | CZ418597A3 (en) |
FI (1) | FI974640A (en) |
MX (1) | MX9710260A (en) |
NO (1) | NO976112L (en) |
PL (1) | PL324319A1 (en) |
SK (1) | SK164297A3 (en) |
WO (1) | WO1997002259A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2370270A (en) * | 2000-12-20 | 2002-06-26 | Lilly Co Eli | Pharmaceutical compounds |
US7335660B2 (en) | 2001-12-19 | 2008-02-26 | Eli Lilly And Company | Isochroman compounds for treatment of CNS disorders |
GB0130339D0 (en) * | 2001-12-19 | 2002-02-06 | Lilly Co Eli | Isochroman compounds |
US7110576B2 (en) | 2002-12-30 | 2006-09-19 | Pitney Bowes Inc. | System and method for authenticating a mailpiece sender |
AU2005238179B2 (en) | 2004-05-05 | 2010-08-26 | F. Hoffmann-La Roche Ag | Arylsulfonyl benzodioxanes useful for modulating the 5-HT6 receptor, the 5-HT2A receptor or both |
RU2389723C2 (en) | 2004-12-21 | 2010-05-20 | Ф. Хоффманн-Ля Рош Аг | Tetraline and indane derivatives and use thereof |
CA2592001A1 (en) | 2004-12-21 | 2006-06-29 | F. Hoffmann-La Roche Ag | Chroman derivatives and their use as 5-ht receptor ligands |
RU2396255C2 (en) | 2004-12-21 | 2010-08-10 | Ф. Хоффманн-Ля Рош Аг | Tetraline and indan derivatives and application thereof |
ES2314749T3 (en) | 2004-12-21 | 2009-03-16 | F. Hoffmann-La Roche Ag | DERIVATIVES OF TETRALINA AND INDANO AND USES OF THE SAME AS 5-HT ANTAGONISTS. |
CA2591810A1 (en) | 2004-12-21 | 2006-06-29 | F.Hoffmann-La Roche Ag | Chroman derivatives and uses thereof in the treatment of cns disorders |
ES2359735T3 (en) | 2005-11-03 | 2011-05-26 | F. Hoffmann-La Roche Ag | ARYLSULPHONYL CHROMANES AS 5-HT6 INHIBITORS. |
BRPI0713742A2 (en) | 2006-06-20 | 2013-02-13 | Hoffmann La Roche | arylsulfonyl naphthalene derivatives and uses of these |
AU2007263084A1 (en) | 2006-06-20 | 2007-12-27 | F. Hoffmann-La Roche Ag | Tetralin and indane derivatives and uses thereof |
CN101472883A (en) | 2006-06-20 | 2009-07-01 | 弗·哈夫曼-拉罗切有限公司 | Arylsulfonamidyl tetralin derivatives and uses thereof |
US20110313197A1 (en) * | 2009-03-05 | 2011-12-22 | Sumitomo Chemical Company, Limited | Method for producing halogen-substituted benzene dimethanol |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1552004A (en) * | 1976-05-26 | 1979-09-05 | Takeda Chemical Industries Ltd | Isochroman derivatives |
NZ277373A (en) * | 1993-12-28 | 1998-07-28 | Upjohn Co | Iso(thio)chroman-1-ylethylpiperazine and -piperidine derivatives (analogues) |
-
1996
- 1996-06-07 PL PL96324319A patent/PL324319A1/en unknown
- 1996-06-07 CA CA002225282A patent/CA2225282A1/en not_active Abandoned
- 1996-06-07 CZ CZ974185A patent/CZ418597A3/en unknown
- 1996-06-07 MX MX9710260A patent/MX9710260A/en unknown
- 1996-06-07 WO PCT/US1996/008681 patent/WO1997002259A1/en not_active Application Discontinuation
- 1996-06-07 AU AU62522/96A patent/AU6252296A/en not_active Abandoned
- 1996-06-07 JP JP9505135A patent/JPH11509532A/en active Pending
- 1996-06-07 EP EP96921264A patent/EP0836599A1/en not_active Withdrawn
- 1996-06-07 SK SK1642-97A patent/SK164297A3/en unknown
- 1996-06-07 BR BR9609631A patent/BR9609631A/en not_active Application Discontinuation
-
1997
- 1997-12-29 NO NO976112A patent/NO976112L/en unknown
- 1997-12-30 FI FI974640A patent/FI974640A/en unknown
Also Published As
Publication number | Publication date |
---|---|
FI974640A0 (en) | 1997-12-30 |
MX9710260A (en) | 1998-03-29 |
BR9609631A (en) | 1999-03-02 |
FI974640A (en) | 1997-12-30 |
CA2225282A1 (en) | 1997-01-23 |
NO976112L (en) | 1998-03-02 |
EP0836599A1 (en) | 1998-04-22 |
JPH11509532A (en) | 1999-08-24 |
SK164297A3 (en) | 1998-09-09 |
PL324319A1 (en) | 1998-05-25 |
CZ418597A3 (en) | 1998-06-17 |
WO1997002259A1 (en) | 1997-01-23 |
NO976112D0 (en) | 1997-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7443496A (en) | Treatment of migraine | |
AU4918796A (en) | Methods of treating or preventing psychiatric disorders | |
AU6578998A (en) | Method of treatment of migraine | |
AU4311896A (en) | Authentication of articles | |
AU5268696A (en) | Novel compounds and methods for therapy | |
AU2675095A (en) | Indol derivatives useful for the treatment of migraine, composition and utilization | |
AU4330596A (en) | Treated mineral fillers | |
PL324992A1 (en) | Novel derivatives of 2,3-dioxotetrahydoquinoxaline | |
AU6252296A (en) | 1,6-disubstituted isochromans for treatment of migraine headaches | |
AU3284395A (en) | Synthesis of 1,1,1,3,3,-pentafluoropropane | |
AU709030B2 (en) | Process for the preparation of pure melamine | |
AU4329396A (en) | Use of 3,4-diphenylchromans | |
AU6253094A (en) | Methods for the treatment of osteoporosis | |
AU6123196A (en) | N-aryl-1,2,4-triazolin-5-ones | |
AU2825295A (en) | Method for the treatment, prevention or minimization of hair loss | |
AU8156094A (en) | Methods of inhibiting breast disorders | |
AU5058196A (en) | Process for the preparation of 1,1-difluoroethane | |
AU4729396A (en) | Process for the preparation of 1,2-benzisothiazolin-3-ones | |
AU7696394A (en) | Process for the preparation of alkylglycosides | |
AU5526196A (en) | Compositions for the treatment of dandruff | |
AU4361696A (en) | New uses of indolo-{2,3b}-quinoxalines | |
AU6042596A (en) | Hydroxyl ions as unique therapeutic agents and compounds tha t modulate ions, compounds | |
AU7113996A (en) | Methods of treating beta-amyloid-associated conditions | |
ZA965548B (en) | 1,6-disubstituted isochromans for treatment of migraine headaches | |
AU9198698A (en) | Process for the preparation of substituted 5,6-dihydro-2h-pyran-2-ones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |